Orange, CA 的 骨髓增生異常症候群 臨床試驗
7 項針對 骨髓增生異常症候群 的研究正在 Orange（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
招募中2 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Children's Hospital of Orange County, Orange
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
招募中1 期
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
招募中1/2 期
- University of California, Irvine, Orange
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Orange
其他城市的 骨髓增生異常症候群 試驗
- Houston, TX43 項研究
- Baldwin Park, CA26 項研究
- New York City, NY21 項研究
- Seattle, WA21 項研究
- Washington, DC20 項研究
- Tampa, FL19 項研究
- Boston, MA19 項研究
- Miami, FL17 項研究
- Durham, NC14 項研究
- Columbus, OH14 項研究
- St. Louis, MO13 項研究
- Atlanta, GA13 項研究
Orange 的其他研究
- 非小細胞肺癌25 項研究
- 轉移性癌症20 項研究
- 大腸直腸癌16 項研究
- 卵巢癌16 項研究
- 胰臟癌15 項研究
- 黑色素瘤14 項研究
- 肝癌（肝細胞癌）14 項研究
- 乳癌14 項研究
- 肺癌14 項研究
- 前列腺癌14 項研究
- 胃癌13 項研究
- 癌症（所有類型）13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。